Research ArticleOriginal Article
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
Jia Lu
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
2Department of Infection Management, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Ting Li
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Zhichao Liao
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Hui Yu
4YuceBio Technology Co., Ltd., Shenzhen 518172, China
Yongtian Zhao
4YuceBio Technology Co., Ltd., Shenzhen 518172, China
Haixiao Wu
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Zhiwu Ren
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Jun Zhao
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Ruwei Xing
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Sheng Teng
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Yun Yang
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Xiangchun Li
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
5Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Kexin Chen
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
5Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Jonathan Trent
6Sarcoma Multidisciplinary Program, Sylvester Comprehensive Cancer Center, The University of Miami, Miami, FL 33136, USA
Jilong Yang
1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
3Key Laboratory of Molecular Cancer Epidemiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
References
- 1.↵
- von Mehren M,
- Randall RL,
- Benjamin RS,
- Boles S,
- Bui MM,
- Casper ES, et al.
- 2.↵
- 3.↵
- 4.↵
- Mulder RL,
- Paulides M,
- Langer T,
- Kremer LC,
- van Dalen EC.
- 5.↵
- 6.↵
- Blay JY,
- van Glabbeke M,
- Verweij J,
- van Oosterom AT,
- Le Cesne A,
- Oosterhuis JW, et al.
- 7.
- 8.↵
- van der Graaf WT,
- Blay JY,
- Chawla SP,
- Kim DW,
- Bui-Nguyen B,
- Casali PG, et al.
- 9.↵
- Boland JM,
- Kwon ED,
- Harrington SM,
- Wampfler JA,
- Tang H,
- Yang P, et al.
- 10.↵
- Raffo Iraolagoitia XL,
- Spallanzani RG,
- Torres NI,
- Araya RE,
- Ziblat A,
- Domaica CI, et al.
- 11.↵
- Brahmer JR,
- Tykodi SS,
- Chow LQM,
- Hwu W-J,
- Topalian SL,
- Hwu P, et al.
- 12.
- Topalian SL,
- Hodi FS,
- Brahmer JR,
- Gettinger SN,
- Smith DC,
- McDermott DF, et al.
- 13.↵
- 14.↵
- Groisberg R,
- Hong DS,
- Behrang A,
- Hess K,
- Janku F,
- Piha-Paul S, et al.
- 15.↵
- 16.↵
- Burgess MA,
- Bolejack V,
- Schuetze S,
- van Tine BA,
- Attia S,
- Riedel RF, et al.
- 17.↵
- 18.↵
- 19.↵
- Xie L,
- Xu J,
- Sun X,
- Guo W,
- Gu J,
- Liu K, et al.
- 20.↵
- Therasse P,
- Arbuck SG,
- Eisenhauer EA,
- Wanders J,
- Kaplan RS,
- Rubinstein L, et al.
- 21.↵
- Eisenhauer EA,
- Therasse P,
- Bogaerts J,
- Schwartz LH,
- Sargent D,
- Ford R, et al.
- 22.↵
- 23.↵
- Trotti A,
- Colevas AD,
- Setser A,
- Rusch V,
- Jaques D,
- Budach V, et al.
- 24.↵
- Yi J,
- Chen L,
- Xiao Y,
- Zhao Z,
- Su X.
- 25.↵
- Wu D,
- Liu Y,
- Li X,
- Liu Y,
- Yang Q,
- Liu Y, et al.
- 26.↵
- 27.↵
- 28.↵
- Luchini C,
- Bibeau F,
- Ligtenberg MJL,
- Singh N,
- Nottegar A,
- Bosse T, et al.
- 29.↵
- Nosaki K,
- Saka H,
- Hosomi Y,
- Baas P,
- de Castro G Jr.,
- Reck M, et al.
- 30.↵
- 31.↵
- Sutherland KD,
- Visvader JE.
- 32.
- Landau DA,
- Carter SL,
- Stojanov P,
- McKenna A,
- Stevenson K,
- Lawrence MS, et al.
- 33.↵
- Zhang J,
- Fujimoto J,
- Zhang J,
- Wedge DC,
- Song X,
- Zhang J, et al.
- 34.↵
- 35.↵
- Hanahan D,
- Coussens LM.
- 36.↵
- 37.↵
- Olingy CE,
- Dinh HQ,
- Hedrick CC.
- 38.↵
- 39.↵
- Hwang RF,
- Moore T,
- Arumugam T,
- Ramachandran V,
- Amos KD,
- Rivera A, et al.
- 40.↵
- Liu K,
- Ren T,
- Huang Y,
- Sun K,
- Bao X,
- Wang S, et al.
- 41.↵
- Zhang H.
- 42.↵
- 43.↵
- 44.↵
- Kim ST,
- Klempner SJ,
- Park SH,
- Park JO,
- Park YS,
- Lim HY, et al.
- 45.
- Shen JK,
- Cote GM,
- Choy E,
- Yang P,
- Harmon D,
- Schwab J, et al.
- 46.↵
- 47.↵
- Lim J,
- Poulin NM,
- Nielsen TO.
- 48.↵
- George J,
- Saito M,
- Tsuta K,
- Iwakawa R,
- Shiraishi K,
- Scheel AH, et al.
- 49.↵
- 50.↵
- Patel SP,
- Kurzrock R.
- 51.↵
- 52.↵
- 53.↵
- Patel KR,
- Martinez A,
- Stahl JM,
- Logan SJ,
- Perricone AJ,
- Ferris MJ, et al.
- 54.↵
- Kalbasi A,
- June CH,
- Haas N,
- Vapiwala N.
- 55.↵
- Tang C,
- Wang X,
- Soh H,
- Seyedin S,
- Cortez MA,
- Krishnan S, et al.
In this issue
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent, Jilong Yang
Cancer Biology & Medicine Jun 2022, 19 (6) 910-930; DOI: 10.20892/j.issn.2095-3941.2021.0270
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent, Jilong Yang
Cancer Biology & Medicine Jun 2022, 19 (6) 910-930; DOI: 10.20892/j.issn.2095-3941.2021.0270
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.